Obstructive hypertrophic cardiomyopathy (oHCM), a subset of HCM, involves significant obstruction in the left ventricular outflow tract (LVOT), leading to symptoms like dyspnea, fatigue, and potentially life-threatening cardiac events. Obstructive hypertrophic cardiomyopathy (oHCM) and nonobstructive hypertrophic cardiomyopathy (nHCM) are usually inherited cardiomyopathies due to gene mutations of the sarcomere leading to abnormal thickening of the myocardium, myocyte disarray, and hyperdynamic contractility. About two-thirds of people with HCM have oHCM, which is more likely to cause symptoms.
The other one-third have nHCM. However, both forms of the condition can carry a risk of heart complications. oHCM is a specific type of HCM. In oHCM, the thickened heart muscle blocks blood flow out of the heart.
ohcm meaning, This blockage can cause more symptoms and complications than HCM without obstruction. Key Difference: While all patients with oHCM have HCM, not all patients with HCM have obstruction. Obstructive hypertrophic cardiomyopathy (oHCM) is a condition in which the heart muscle thickens excessively, becoming stiff and obstructing blood flow. The abbreviation OHCM stands for obstructive hypertrophic cardiomyopathy and is mostly used in the following categories: Medical, Biology. Whether you're exploring these categories or simply seeking a quick definition, this page provides comprehensive information on OHCM.
